High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort

Laura Gabriela González Briceño1,2, Dulanjalee Kariyawasam1, Dinane Samara-Boustani1

  • 1Hôpital Universitaire Necker-Enfants Malades - Assistance Publique Hôpitaux de Paris (APHP), Service d'Endocrinologie, gynécologie et diabétologie pédiatrique, Institut IMAGINE (affiliate), 75015 Paris, France.

Insights

Pediatric brain tumor patients frequently develop endocrine complications, including growth hormone deficiency and hypothyroidism, particularly those with suprasellar tumors. Early endocrine consultation is crucial for managing these common disorders.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Endocrinology

Background:

  • Endocrine complications are a significant concern for children diagnosed with primary brain tumors.
  • Long-term follow-up is essential to monitor and manage these potential sequelae.

Purpose of the Study:

  • To characterize the endocrine follow-up and complications in a cohort of pediatric patients with primary brain tumors.
  • To compare endocrine outcomes based on tumor location, specifically suprasellar versus non-suprasellar.

Main Methods:

  • A noninterventional observational study involving 221 pediatric patients with primary brain tumors.
  • Data were collected retrospectively from medical records at a Pediatric Endocrinology Department.
  • Analysis included tumor type, location, treatments, and various endocrine function tests and anthropometric measurements.

Main Results:

  • High prevalence of growth hormone deficiency (GHD), hypothyroidism, ACTH deficiency, and hypogonadotropic hypogonadism, particularly in suprasellar (SS) tumors.
  • Non-suprasellar (NSS) tumors were associated with lower adult height and higher post-chemotherapy gonadal toxicity.
  • Increased BMI and obesity incidence were observed in both SS and NSS groups post-treatment. Thyroid nodules and cancers were noted following radiotherapy.

Conclusions:

  • Pediatric brain tumor patients experience a high incidence of early-onset endocrine disorders.
  • Routine endocrine assessment and nutritional evaluation are recommended for all brain tumor patients, especially those with suprasellar tumors or after hypothalamus/pituitary irradiation.
Abstract